DFTX | Definium TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$33.41
+$0.94 (+2.89%)

Definium Therapeutics (DFTX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.

The 50 SMA sits above the 200 on the daily. The 200-day average is 2 sessions old; Cruxta projects nothing until it has 30. Price sits between the 50 and the 200 on the daily and below both on the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $33.41 vs 50 $37.32 / 200 $29.78
Projection
No cross projected
Test
No active test
Last cross
No cross on record

Weekly

No weekly data

4-hour as of 3 Nov 16:00 ET

Price
below both $33.41 vs 50 $35.60 / 200 $39.68
Projection
No cross projected
Test
No active test
Last cross
Death cross 12 Oct 2026 ยท projected 16 bars out

Cross history

1
cross on record since 2026
0 golden1 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
12 Oct 2026Death4-hour16 bars outNot tested

About DFTX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$72.4M
4-hour coverageYes, since Jan 2026
History on recordSince 2026
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.